Bondesson M, Hao R, Lin CY, Williams C, Gustafsson JA. Estrogen receptor signaling during vertebrate development. Biochim Biophys Acta. 2015;1849:142–51.
Article
CAS
PubMed
Google Scholar
Jones ME, Boon WC, Proietto J, Simpson ER. Of mice and men: the evolving phenotype of aromatase deficiency. Trends Endocrinol Metab. 2006;17:55–64.
Article
PubMed
Google Scholar
Bulun SE, Chen D, Moy I, Brooks DC, Zhao H. Aromatase, breast cancer and obesity: a complex interaction. Trends Endocrinol Metab. 2012;23:83–9.
Article
CAS
PubMed
Google Scholar
Macias H, Hinck L. Mammary gland development. Wiley Interdiscip Rev Dev Biol. 2012;1:533–57.
Article
CAS
PubMed
PubMed Central
Google Scholar
Brisken C, O’Malley B. Hormone action in the mammary gland. Cold Spring Harb Perspect Biol. 2010;2:a003178.
Article
CAS
PubMed
PubMed Central
Google Scholar
Turashvili G, Bouchal J, Burkadze G, Kolar Z. Mammary gland development and cancer. Cesk Patol. 2005;41:94–101.
CAS
PubMed
Google Scholar
Dahlman-Wright K, Cavailles V, Fuqua SA, Jordan VC, Katzenellenbogen JA, Korach KS, et al. International Union of Pharmacology. LXIV. Estrogen receptors. Pharmacol Rev. 2006;58:773–81.
Article
CAS
PubMed
Google Scholar
Hammes SR, Levin ER. Minireview: Recent advances in extranuclear steroid receptor actions. Endocrinology. 2011;152:4489–95.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wu Q, Chambliss K, Umetani M, Mineo C, Shaul PW. Non-nuclear Estrogen Receptor Signaling in Endothelium. J Biol Chem. 2011;286:14737–43.
Article
CAS
PubMed
PubMed Central
Google Scholar
Prossnitz ER, Barton M. Estrogen biology: New Insights into GPER function and clinical opportunities. Mol Cell Endocrinol. 2014;389:71–83.
Article
CAS
PubMed
PubMed Central
Google Scholar
Prossnitz ER, Arterburn JB: International Union of Basic and Clinical Pharmacology: G protein-coupled estrogen receptor (GPER) and its pharmacologic modulators. Pharm Rev. 2015;67:505-40.
Prossnitz ER, Barton M. The G-protein-coupled estrogen receptor GPER in health and disease. Nat Rev Endocrinol. 2011;7:715–26.
Article
CAS
PubMed
PubMed Central
Google Scholar
Prossnitz ER, Arterburn JB, Smith HO, Oprea TI, Sklar LA, Hathaway HJ. Estrogen action via the transmembrane receptor GPR30. Annu Rev Physiol. 2008;70:165–90.
Article
CAS
PubMed
Google Scholar
Dennis MK, Field AS, Burai R, Ramesh C, Petrie WK, Bologa CG, et al. Identification of a GPER/GPR30 antagonist with improved estrogen receptor counterselectivity. J Steroid Biochem Mol Biol. 2011;127:358–66.
Article
CAS
PubMed
PubMed Central
Google Scholar
Dennis MK, Burai R, Ramesh C, Petrie WK, Alcon SN, Nayak TK, et al. In vivo effects of a GPR30 antagonist. Nat Chem Biol. 2009;5:421–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bologa CG, Revankar CM, Young SM, Edwards BS, Arterburn JB, Kiselyov AS, et al. Virtual and biomolecular screening converge on a selective agonist for GPR30. Nat Chem Biol. 2006;2:207–12.
Article
CAS
PubMed
Google Scholar
Prossnitz ER, Hathaway HJ. What have we learned about GPER function in physiology and disease from knockout mice? J Steroid Biochem Mol Biol. 2015;153:114–26.
Article
CAS
PubMed
PubMed Central
Google Scholar
Marjon NA, Hu C, Hathaway HJ, Prossnitz ER. G protein-coupled estrogen receptor regulates mammary tumorigenesis and metastasis. Mol Cancer Res. 2014;12:1644–54.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lappano R, Pisano A, Maggiolini M. GPER Function in Breast Cancer: An Overview. Front Endocrinol (Lausanne). 2014;5:66.
Google Scholar
Brunsing RL, Owens KS, Prossnitz ER. The G protein-coupled estrogen receptor (GPER) agonist G-1 expands the regulatory T-cell population under TH17-polarizing conditions. J Immunother. 2013;36:190–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Brunsing RL, Prossnitz ER. Induction of interleukin-10 in the T helper type 17 effector population by the G protein coupled estrogen receptor (GPER) agonist G-1. Immunology. 2011;134:93–106.
Article
CAS
PubMed
PubMed Central
Google Scholar
Meyer MR, Fredette NC, Howard TA, Hu C, Ramesh C, Daniel C, et al. G protein-coupled Estrogen Receptor protects from atherosclerosis. Nat Sci Rep. 2014;4:7564.
Article
CAS
Google Scholar
Barton M, Prossnitz ER: Emerging roles of GPER in diabetes and atherosclerosis. Trends Endocrinol Metab. 2015. (in press).
Sharma G, Hu C, Brigman JL, Zhu G, Hathaway HJ, Prossnitz ER. GPER deficiency in male mice results in insulin resistance, dyslipidemia, and a proinflammatory state. Endocrinology. 2013;154:4136–45.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sharma G, Prossnitz ER. Mechanisms of estradiol-induced insulin secretion by the G protein-coupled estrogen receptor GPR30/GPER in pancreatic beta-cells. Endocrinology. 2011;152:3030–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sharma G, Prossnitz ER: GPER/GPR30 knockout mice: effects of GPER on metabolism. In: Methods Mol Biol. Volume: The Estrogen Receptors. Edited by Walker JM: Springer; 2015: (in press).
Filardo EJ, Quinn JA, Bland KI, Frackelton Jr AR. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol. 2000;14:1649–60.
Article
CAS
PubMed
Google Scholar
Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science. 2005;307:1625–30.
Article
CAS
PubMed
Google Scholar
Vanhaesebroeck B, Guillermet-Guibert J, Graupera M, Bilanges B. The emerging mechanisms of isoform-specific PI3K signalling. Nat Rev Mol Cell Biol. 2010;11:329–41.
Article
CAS
PubMed
Google Scholar
Foukas LC, Claret M, Pearce W, Okkenhaug K, Meek S, Peskett E, et al. Critical role for the p110alpha phosphoinositide-3-OH kinase in growth and metabolic regulation. Nature. 2006;441:366–70.
Article
CAS
PubMed
Google Scholar
Kumar A, Redondo-Munoz J, Perez-Garcia V, Cortes I, Chagoyen M, Carrera AC. Nuclear but not cytosolic phosphoinositide 3-kinase beta has an essential function in cell survival. Mol Cell Biol. 2011;31:2122–33.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kumar A, Fernandez-Capetillo O, Carrera AC. Nuclear phosphoinositide 3-kinase beta controls double-strand break DNA repair. Proc Natl Acad Sci U S A. 2010;107:7491–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Marques M, Kumar A, Poveda AM, Zuluaga S, Hernandez C, Jackson S, et al. Specific function of phosphoinositide 3-kinase beta in the control of DNA replication. Proc Natl Acad Sci U S A. 2009;106:7525–30.
Article
CAS
PubMed
PubMed Central
Google Scholar
Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell. 1999;96:857–68.
Article
CAS
PubMed
Google Scholar
Calnan DR, Brunet A. The FoxO code. Oncogene. 2008;27:2276–88.
Article
CAS
PubMed
Google Scholar
Burgering BM. A brief introduction to FOXOlogy. Oncogene. 2008;27:2258–62.
Article
CAS
PubMed
Google Scholar
Yang JY, Hung MC. Deciphering the role of forkhead transcription factors in cancer therapy. Curr Drug Targets. 2011;12:1284–90.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chiacchiera F, Simone C. The AMPK-FoxO3A axis as a target for cancer treatment. Cell Cycle. 2010;9:1091–6.
Article
CAS
PubMed
Google Scholar
Singh A, Plati J, Khosravi-Far R. Harnessing the tumor suppressor function of FOXO as an alternative therapeutic approach in cancer. Curr Drug Targets. 2011;12:1311–21.
Article
CAS
PubMed
Google Scholar
Dansen TB, Burgering BM. Unravelling the tumor-suppressive functions of FOXO proteins. Trends Cell Biol. 2008;18:421–9.
Article
CAS
PubMed
Google Scholar
Zheng WH, Kar S, Quirion R. Insulin-like growth factor-1-induced phosphorylation of the forkhead family transcription factor FKHRL1 is mediated by Akt kinase in PC12 cells. J Biol Chem. 2000;275:39152–8.
Article
CAS
PubMed
Google Scholar
Jacobs FM, van der Heide LP, Wijchers PJ, Burbach JP, Hoekman MF, Smidt MP. FoxO6, a novel member of the FoxO class of transcription factors with distinct shuttling dynamics. J Biol Chem. 2003;278:35959–67.
Article
CAS
PubMed
Google Scholar
Wen Q, Duan X, Liao R, Little P, Gao G, Jiang H, et al. Characterization of intracellular translocation of Forkhead transcription factor O (FoxO) members induced by NGF in PC12 cells. Neurosci Lett. 2011;498:31–6.
Article
CAS
PubMed
Google Scholar
Ho KK, McGuire VA, Koo CY, Muir KW, De Olano N, Maifoshie E, et al. Phosphorylation of FOXO3a on Ser-7 by p38 promotes its nuclear localization in response to doxorubicin. J Biol Chem. 2012;287:1545–55.
Article
CAS
PubMed
Google Scholar
Habashy HO, Rakha EA, Aleskandarany M, Ahmed MA, Green AR, Ellis IO, et al. FOXO3a nuclear localisation is associated with good prognosis in luminal-like breast cancer. Breast Cancer Res Treat. 2011;129:11–21.
Article
CAS
PubMed
Google Scholar
Ariazi EA, Brailoiu E, Yerrum S, Shupp HA, Slifker MJ, Cunliffe HE, et al. The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells. Cancer Res. 2010;70:1184–94.
Article
CAS
PubMed
PubMed Central
Google Scholar
Burow ME, Weldon CB, Chiang TC, Tang Y, Collins-Burow BM, Rolfe K, et al. Differences in protein kinase C and estrogen receptor alpha, beta expression and signaling correlate with apoptotic sensitivity of MCF-7 breast cancer cell variants. Int J Oncol. 2000;16:1179–87.
CAS
PubMed
Google Scholar
Datta SR, Brunet A, Greenberg ME. Cellular survival: a play in three Akts. Genes Dev. 1999;13:2905–27.
Article
CAS
PubMed
Google Scholar
Burgering BM, Coffer PJ. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature. 1995;376:599–602.
Article
CAS
PubMed
Google Scholar
Thomas P, Pang Y, Filardo EJ, Dong J. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology. 2005;146:624–32.
Article
CAS
PubMed
Google Scholar
Mo Z, Liu M, Yang F, Luo H, Li Z, Tu G, et al. GPR30 as an initiator of tamoxifen resistance in hormone-dependent breast cancer. Breast Cancer Res. 2013;15:R114.
Article
PubMed
PubMed Central
Google Scholar
Catalano S, Giordano C, Panza S, Chemi F, Bonofiglio D, Lanzino M, et al. Tamoxifen through GPER upregulates aromatase expression: a novel mechanism sustaining tamoxifen-resistant breast cancer cell growth. Breast Cancer Res Treat. 2014;146:273–85.
Article
CAS
PubMed
Google Scholar
Ignatov A, Ignatov T, Weissenborn C, Eggemann H, Bischoff J, Semczuk A, et al. G-protein-coupled estrogen receptor GPR30 and tamoxifen resistance in breast cancer. Breast Cancer Res Treat. 2011;128:457–66.
Article
CAS
PubMed
Google Scholar
Ignatov A, Ignatov T, Roessner A, Costa SD, Kalinski T. Role of GPR30 in the mechanisms of tamoxifen resistance in breast cancer MCF-7 cells. Breast Cancer Res Treat. 2010;123:87–96.
Article
CAS
PubMed
Google Scholar
Petrie WK, Dennis MK, Hu C, Dai D, Arterburn JB, Smith HO, et al. G protein-coupled estrogen receptor-selective ligands modulate endometrial tumor growth. Obstet Gynecol Int. 2013;2013:472720.
Article
PubMed
PubMed Central
Google Scholar
Vivacqua A, Bonofiglio D, Recchia AG, Musti AM, Picard D, Ando S, et al. The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17b-estradiol and hydroxytamoxifen in endometrial cancer cells. Mol Endocrinol. 2006;20:631–46.
Article
CAS
PubMed
Google Scholar
Tsai CL, Wu HM, Lin CY, Lin YJ, Chao A, Wang TH, et al. Estradiol and tamoxifen induce cell migration through GPR30 and activation of focal adhesion kinase (FAK) in endometrial cancers with low or without nuclear estrogen receptor alpha (ERalpha). PLoS One. 2013;8, e72999.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chen Y, Li Z, He Y, Shang D, Pan J, Wang H, et al. Estrogen and pure antiestrogen fulvestrant (ICI 182 780) augment cell-matrigel adhesion of MCF-7 breast cancer cells through a novel G protein coupled estrogen receptor (GPR30)-to-calpain signaling axis. Toxicol Appl Pharmacol. 2014;275:176–81.
Article
CAS
PubMed
Google Scholar
Scaling AL, Prossnitz ER, Hathaway HJ. GPER mediates estrogen-induced signaling and proliferation in human breast epithelial cells and normal and malignant breast. Horm Cancer. 2014;5:146–60.
Article
CAS
PubMed
PubMed Central
Google Scholar
Janicke RU, Sprengart ML, Wati MR, Porter AG. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J Biol Chem. 1998;273:9357–60.
Article
CAS
PubMed
Google Scholar
Sunters A, Madureira PA, Pomeranz KM, Aubert M, Brosens JJ, Cook SJ, et al. Paclitaxel-induced nuclear translocation of FOXO3a in breast cancer cells is mediated by c-Jun NH2-terminal kinase and Akt. Cancer Res. 2006;66:212–20.
Article
CAS
PubMed
Google Scholar
Williams C, Lin CY. Oestrogen receptors in breast cancer: basic mechanisms and clinical implications. Ecancermedicalscience. 2013;7:370.
PubMed
PubMed Central
Google Scholar
Zou Y, Tsai WB, Cheng CJ, Hsu C, Chung YM, Li PC, et al. Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis. Breast Cancer Res. 2008;10:R21.
Article
PubMed
PubMed Central
Google Scholar
Sisci D, Maris P, Cesario MG, Anselmo W, Coroniti R, Trombino GE, et al. The estrogen receptor alpha is the key regulator of the bifunctional role of FoxO3a transcription factor in breast cancer motility and invasiveness. Cell Cycle. 2013;12:3405–20.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sisci D, Middea E, Morelli C, Lanzino M, Aquila S, Rizza P, et al. 17beta-estradiol enhances alpha (5) integrin subunit gene expression through ERalpha-Sp1 interaction and reduces cell motility and invasion of ERalpha-positive breast cancer cells. Breast Cancer Res Treat. 2010;124:63–77.
Article
CAS
PubMed
Google Scholar
De Donatis A, Ranaldi F, Cirri P. Reciprocal control of cell proliferation and migration. Cell Commun Signal. 2010;8:20.
Article
PubMed
PubMed Central
Google Scholar
Madeo A, Maggiolini M. Nuclear alternate estrogen receptor GPR30 mediates 17beta-estradiol-induced gene expression and migration in breast cancer-associated fibroblasts. Cancer Res. 2010;70:6036–46.
Article
CAS
PubMed
Google Scholar